Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cell Transplantation | 70 | 2024 | 5753 | 5.450 |
Why?
|
Killer Cells, Natural | 32 | 2024 | 2210 | 5.090 |
Why?
|
Graft vs Host Disease | 45 | 2024 | 3079 | 4.020 |
Why?
|
Cyclophosphamide | 30 | 2024 | 2234 | 3.920 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 10 | 2021 | 266 | 3.610 |
Why?
|
Leukemia, Myeloid, Acute | 33 | 2024 | 3636 | 3.280 |
Why?
|
Transplantation Conditioning | 27 | 2024 | 1635 | 2.720 |
Why?
|
Hematologic Neoplasms | 14 | 2024 | 1926 | 1.730 |
Why?
|
Interleukin-15 | 7 | 2024 | 186 | 1.670 |
Why?
|
Lymphocyte Depletion | 5 | 2020 | 606 | 1.570 |
Why?
|
Immunotherapy, Adoptive | 12 | 2024 | 1504 | 1.380 |
Why?
|
Myelodysplastic Syndromes | 12 | 2024 | 1404 | 1.310 |
Why?
|
Immunologic Memory | 7 | 2024 | 1377 | 1.310 |
Why?
|
HLA Antigens | 8 | 2021 | 1339 | 1.290 |
Why?
|
Transplantation, Homologous | 20 | 2024 | 4860 | 1.220 |
Why?
|
Cord Blood Stem Cell Transplantation | 5 | 2021 | 316 | 1.220 |
Why?
|
Leukemia | 5 | 2021 | 1521 | 1.050 |
Why?
|
Tissue Donors | 9 | 2022 | 2392 | 1.010 |
Why?
|
Bone Marrow Diseases | 2 | 2017 | 234 | 0.920 |
Why?
|
Histocompatibility | 5 | 2019 | 327 | 0.910 |
Why?
|
Cytokines | 7 | 2024 | 7438 | 0.900 |
Why?
|
Granulocyte Colony-Stimulating Factor | 4 | 2021 | 633 | 0.890 |
Why?
|
Receptors, IgG | 3 | 2015 | 562 | 0.820 |
Why?
|
Myeloablative Agonists | 4 | 2019 | 215 | 0.820 |
Why?
|
Opportunistic Infections | 4 | 2023 | 376 | 0.780 |
Why?
|
Cytomegalovirus Infections | 6 | 2023 | 838 | 0.770 |
Why?
|
Multiple Myeloma | 5 | 2024 | 5194 | 0.750 |
Why?
|
Lymphocyte Transfusion | 2 | 2020 | 236 | 0.690 |
Why?
|
Cytotoxicity, Immunologic | 7 | 2024 | 1352 | 0.620 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2024 | 1362 | 0.620 |
Why?
|
Hematopoietic Stem Cell Mobilization | 3 | 2021 | 227 | 0.600 |
Why?
|
T-Lymphocytes | 12 | 2024 | 10264 | 0.570 |
Why?
|
Neoplasms | 10 | 2024 | 22350 | 0.560 |
Why?
|
Cytomegalovirus | 3 | 2021 | 754 | 0.550 |
Why?
|
Epitopes | 3 | 2020 | 2526 | 0.540 |
Why?
|
Sarcoma, Myeloid | 1 | 2017 | 52 | 0.540 |
Why?
|
Tongue Diseases | 1 | 2017 | 70 | 0.540 |
Why?
|
Salvage Therapy | 4 | 2021 | 1274 | 0.510 |
Why?
|
Interleukin-2 | 2 | 2022 | 1895 | 0.510 |
Why?
|
Azacitidine | 5 | 2024 | 335 | 0.500 |
Why?
|
Humans | 122 | 2024 | 766766 | 0.470 |
Why?
|
Lymphocyte Subsets | 1 | 2015 | 313 | 0.460 |
Why?
|
Tongue | 1 | 2017 | 406 | 0.440 |
Why?
|
Leukemia, Myeloid | 1 | 2016 | 695 | 0.420 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2017 | 614 | 0.420 |
Why?
|
Acetates | 1 | 2014 | 314 | 0.420 |
Why?
|
Disease-Free Survival | 12 | 2021 | 6850 | 0.410 |
Why?
|
Serum Albumin | 1 | 2016 | 675 | 0.410 |
Why?
|
Recurrence | 10 | 2024 | 8507 | 0.380 |
Why?
|
Virus Activation | 1 | 2013 | 322 | 0.380 |
Why?
|
Aged | 45 | 2024 | 171343 | 0.380 |
Why?
|
ADAM Proteins | 1 | 2013 | 243 | 0.370 |
Why?
|
Adult | 57 | 2024 | 223307 | 0.370 |
Why?
|
Lymphocyte Activation | 5 | 2022 | 5503 | 0.360 |
Why?
|
Hematologic Diseases | 1 | 2015 | 502 | 0.360 |
Why?
|
Middle Aged | 50 | 2024 | 223257 | 0.360 |
Why?
|
Siblings | 7 | 2021 | 828 | 0.350 |
Why?
|
Immunophenotyping | 1 | 2015 | 1867 | 0.350 |
Why?
|
Young Adult | 28 | 2024 | 59939 | 0.350 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2015 | 504 | 0.350 |
Why?
|
ABO Blood-Group System | 1 | 2013 | 381 | 0.350 |
Why?
|
Retrospective Studies | 35 | 2024 | 81635 | 0.340 |
Why?
|
Histocompatibility Testing | 4 | 2020 | 726 | 0.340 |
Why?
|
Immunocompromised Host | 2 | 2017 | 865 | 0.340 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2009 | 65 | 0.320 |
Why?
|
Hepatic Veno-Occlusive Disease | 2 | 2022 | 221 | 0.310 |
Why?
|
Remission Induction | 4 | 2019 | 2413 | 0.310 |
Why?
|
Survival Rate | 11 | 2021 | 12825 | 0.300 |
Why?
|
GPI-Linked Proteins | 2 | 2024 | 472 | 0.300 |
Why?
|
Quinazolines | 1 | 2014 | 1367 | 0.290 |
Why?
|
Bone Marrow Cells | 1 | 2015 | 2413 | 0.290 |
Why?
|
Lymphoma | 1 | 2017 | 1900 | 0.290 |
Why?
|
Peptides | 1 | 2019 | 4344 | 0.280 |
Why?
|
Bone Marrow Transplantation | 5 | 2023 | 2730 | 0.280 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4904 | 0.280 |
Why?
|
Health Personnel | 1 | 2020 | 3384 | 0.270 |
Why?
|
Immunotherapy | 6 | 2024 | 4747 | 0.270 |
Why?
|
Immunosuppressive Agents | 7 | 2021 | 4215 | 0.270 |
Why?
|
Proteins | 3 | 2018 | 6002 | 0.270 |
Why?
|
K562 Cells | 4 | 2024 | 645 | 0.260 |
Why?
|
Interferon-gamma | 3 | 2015 | 3158 | 0.260 |
Why?
|
Male | 44 | 2024 | 364142 | 0.250 |
Why?
|
Antimetabolites, Antineoplastic | 3 | 2021 | 646 | 0.250 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2023 | 617 | 0.250 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2024 | 3607 | 0.240 |
Why?
|
Female | 44 | 2024 | 396520 | 0.240 |
Why?
|
HLA-A2 Antigen | 2 | 2022 | 207 | 0.240 |
Why?
|
Cell Line, Tumor | 8 | 2024 | 17088 | 0.230 |
Why?
|
Virus Diseases | 3 | 2021 | 720 | 0.230 |
Why?
|
Cardiomyopathies | 1 | 2017 | 2059 | 0.230 |
Why?
|
Antiviral Agents | 2 | 2014 | 3070 | 0.230 |
Why?
|
Adolescent | 22 | 2024 | 88904 | 0.220 |
Why?
|
Registries | 2 | 2019 | 8351 | 0.220 |
Why?
|
Liver Transplantation | 1 | 2016 | 2416 | 0.220 |
Why?
|
Survival Analysis | 6 | 2019 | 10100 | 0.210 |
Why?
|
Activated-Leukocyte Cell Adhesion Molecule | 1 | 2022 | 21 | 0.210 |
Why?
|
Physicians | 1 | 2020 | 4591 | 0.200 |
Why?
|
Adrenergic Agents | 1 | 2022 | 72 | 0.200 |
Why?
|
Acute Disease | 5 | 2021 | 7241 | 0.200 |
Why?
|
Haplotypes | 3 | 2017 | 2727 | 0.200 |
Why?
|
Antigens, CD34 | 1 | 2024 | 656 | 0.200 |
Why?
|
Graft Survival | 3 | 2018 | 3904 | 0.200 |
Why?
|
Antineoplastic Agents | 3 | 2024 | 13643 | 0.190 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2021 | 5329 | 0.190 |
Why?
|
Herpesviridae | 1 | 2021 | 104 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9404 | 0.180 |
Why?
|
Chimerism | 1 | 2021 | 154 | 0.170 |
Why?
|
Single-Chain Antibodies | 1 | 2020 | 114 | 0.170 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2021 | 1642 | 0.170 |
Why?
|
Heterocyclic Compounds | 1 | 2021 | 245 | 0.170 |
Why?
|
BK Virus | 1 | 2020 | 120 | 0.160 |
Why?
|
Adoptive Transfer | 3 | 2016 | 828 | 0.160 |
Why?
|
Bone Marrow | 3 | 2019 | 2926 | 0.150 |
Why?
|
Graft vs Leukemia Effect | 2 | 2020 | 122 | 0.150 |
Why?
|
Treatment Failure | 1 | 2024 | 2659 | 0.150 |
Why?
|
Blood Donors | 2 | 2019 | 344 | 0.150 |
Why?
|
Dermatitis | 1 | 2019 | 203 | 0.140 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2017 | 1560 | 0.140 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 319 | 0.140 |
Why?
|
Ustilaginales | 1 | 2017 | 1 | 0.140 |
Why?
|
Patient Care Management | 1 | 2020 | 302 | 0.140 |
Why?
|
Transplantation, Autologous | 2 | 2021 | 2127 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2020 | 4652 | 0.140 |
Why?
|
Genes, Neoplasm | 1 | 2019 | 369 | 0.140 |
Why?
|
Community-Acquired Infections | 1 | 2021 | 470 | 0.140 |
Why?
|
Dermatomycoses | 1 | 2017 | 45 | 0.140 |
Why?
|
Sulfonamides | 2 | 2024 | 1982 | 0.140 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2016 | 56 | 0.140 |
Why?
|
Fungemia | 1 | 2017 | 57 | 0.140 |
Why?
|
Viremia | 2 | 2016 | 727 | 0.130 |
Why?
|
Recombinant Fusion Proteins | 4 | 2018 | 3738 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8621 | 0.130 |
Why?
|
Lymphoproliferative Disorders | 1 | 2020 | 527 | 0.130 |
Why?
|
Lymphoma, T-Cell | 1 | 2019 | 308 | 0.130 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 2022 | 897 | 0.130 |
Why?
|
Immunity, Innate | 4 | 2022 | 3077 | 0.130 |
Why?
|
Nitriles | 1 | 2021 | 981 | 0.130 |
Why?
|
Yeasts | 1 | 2017 | 278 | 0.130 |
Why?
|
Premedication | 1 | 2016 | 245 | 0.130 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 239 | 0.120 |
Why?
|
Janus Kinase 1 | 1 | 2015 | 108 | 0.120 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12534 | 0.120 |
Why?
|
Treatment Outcome | 8 | 2021 | 65273 | 0.120 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2017 | 340 | 0.120 |
Why?
|
Mucositis | 1 | 2016 | 107 | 0.120 |
Why?
|
Anemia, Aplastic | 1 | 2017 | 231 | 0.120 |
Why?
|
Age Factors | 4 | 2024 | 18397 | 0.110 |
Why?
|
Interleukin-18 | 2 | 2014 | 251 | 0.110 |
Why?
|
Cytokine-Induced Killer Cells | 1 | 2014 | 6 | 0.110 |
Why?
|
Neuroblastoma | 1 | 2022 | 1266 | 0.110 |
Why?
|
Heparin | 1 | 2021 | 1636 | 0.110 |
Why?
|
Mice | 8 | 2024 | 81889 | 0.110 |
Why?
|
Incidence | 9 | 2023 | 21525 | 0.110 |
Why?
|
Primary Myelofibrosis | 1 | 2015 | 209 | 0.110 |
Why?
|
Respiratory Tract Infections | 1 | 2021 | 1008 | 0.110 |
Why?
|
Interleukin-12 | 2 | 2014 | 581 | 0.110 |
Why?
|
Ligands | 2 | 2019 | 3275 | 0.110 |
Why?
|
Stem Cell Transplantation | 1 | 2022 | 1600 | 0.110 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 1 | 2012 | 30 | 0.100 |
Why?
|
Receptors, Interleukin-12 | 1 | 2012 | 26 | 0.100 |
Why?
|
Isoantibodies | 1 | 2017 | 681 | 0.100 |
Why?
|
Receptors, Interleukin-18 | 1 | 2012 | 25 | 0.100 |
Why?
|
Piperidines | 1 | 2021 | 1663 | 0.100 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily C | 1 | 2012 | 38 | 0.100 |
Why?
|
L-Selectin | 1 | 2013 | 212 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2534 | 0.100 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2014 | 306 | 0.100 |
Why?
|
Heart Failure | 1 | 2017 | 11882 | 0.100 |
Why?
|
Necrosis | 1 | 2017 | 1616 | 0.100 |
Why?
|
Receptors, Interleukin-2 | 1 | 2014 | 565 | 0.100 |
Why?
|
Janus Kinase 2 | 1 | 2015 | 562 | 0.100 |
Why?
|
Exanthema | 1 | 2017 | 502 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1882 | 0.100 |
Why?
|
Adipocytes | 1 | 2019 | 1196 | 0.100 |
Why?
|
Antifungal Agents | 1 | 2017 | 769 | 0.100 |
Why?
|
Receptors, KIR | 2 | 2024 | 114 | 0.100 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 1434 | 0.090 |
Why?
|
Hodgkin Disease | 1 | 2019 | 1384 | 0.090 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15416 | 0.090 |
Why?
|
Netherlands | 1 | 2016 | 2277 | 0.090 |
Why?
|
Saccharomyces cerevisiae | 1 | 2022 | 2678 | 0.090 |
Why?
|
Transplantation Immunology | 1 | 2013 | 540 | 0.090 |
Why?
|
Pyrazoles | 1 | 2021 | 2030 | 0.090 |
Why?
|
Myeloproliferative Disorders | 1 | 2017 | 616 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2023 | 1946 | 0.090 |
Why?
|
Cell Proliferation | 3 | 2016 | 10445 | 0.090 |
Why?
|
Propensity Score | 1 | 2018 | 1972 | 0.090 |
Why?
|
Syndrome | 1 | 2016 | 3271 | 0.080 |
Why?
|
Animals | 9 | 2024 | 168930 | 0.080 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1838 | 0.080 |
Why?
|
Lectins, C-Type | 1 | 2012 | 592 | 0.080 |
Why?
|
Pyrimidines | 1 | 2021 | 3043 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 945 | 0.080 |
Why?
|
Chronic Disease | 5 | 2024 | 9357 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2016 | 1390 | 0.080 |
Why?
|
Vidarabine | 2 | 2021 | 342 | 0.080 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2017 | 1750 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2023 | 5890 | 0.070 |
Why?
|
Antigens, CD | 2 | 2022 | 4032 | 0.070 |
Why?
|
Benzimidazoles | 1 | 2013 | 862 | 0.070 |
Why?
|
Secondary Prevention | 1 | 2013 | 1469 | 0.070 |
Why?
|
Protein Transport | 1 | 2013 | 1942 | 0.070 |
Why?
|
DNA Methylation | 1 | 2021 | 4427 | 0.070 |
Why?
|
Neutrophils | 1 | 2020 | 3782 | 0.070 |
Why?
|
Coculture Techniques | 2 | 2023 | 1337 | 0.070 |
Why?
|
Herpesvirus 4, Human | 2 | 2023 | 1080 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2016 | 3227 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2948 | 0.060 |
Why?
|
Donor Selection | 2 | 2019 | 242 | 0.060 |
Why?
|
Macrophages | 1 | 2021 | 5783 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5795 | 0.060 |
Why?
|
Simplexvirus | 1 | 2009 | 805 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2022 | 7868 | 0.060 |
Why?
|
Risk | 2 | 2016 | 9602 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4570 | 0.060 |
Why?
|
Cytarabine | 2 | 2017 | 696 | 0.060 |
Why?
|
Mutation | 2 | 2022 | 30213 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1964 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6512 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2017 | 5143 | 0.060 |
Why?
|
Echocardiography | 1 | 2017 | 5037 | 0.060 |
Why?
|
Time Factors | 3 | 2017 | 40149 | 0.060 |
Why?
|
Cell Membrane | 1 | 2013 | 3641 | 0.050 |
Why?
|
Cells, Cultured | 3 | 2014 | 18984 | 0.050 |
Why?
|
Risk Factors | 5 | 2020 | 74881 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39309 | 0.050 |
Why?
|
B-Cell Maturation Antigen | 1 | 2024 | 148 | 0.050 |
Why?
|
Stroke Volume | 1 | 2017 | 5618 | 0.050 |
Why?
|
Neoplasm, Residual | 2 | 2018 | 1012 | 0.050 |
Why?
|
Fetal Proteins | 1 | 2022 | 100 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3721 | 0.050 |
Why?
|
Comorbidity | 1 | 2017 | 10580 | 0.050 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2021 | 317 | 0.050 |
Why?
|
Cohort Studies | 2 | 2015 | 41710 | 0.050 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2022 | 262 | 0.050 |
Why?
|
Busulfan | 1 | 2021 | 264 | 0.050 |
Why?
|
Polydeoxyribonucleotides | 1 | 2022 | 136 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14652 | 0.040 |
Why?
|
Immunologic Factors | 2 | 2022 | 1594 | 0.040 |
Why?
|
Mice, SCID | 2 | 2017 | 2628 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2021 | 6307 | 0.040 |
Why?
|
Ohio | 1 | 2021 | 320 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12064 | 0.040 |
Why?
|
Benzylamines | 1 | 2021 | 251 | 0.040 |
Why?
|
Fever | 2 | 2017 | 1607 | 0.040 |
Why?
|
Tacrolimus | 1 | 2023 | 753 | 0.040 |
Why?
|
Chemokine CXCL12 | 1 | 2021 | 457 | 0.040 |
Why?
|
Consensus | 2 | 2019 | 3208 | 0.040 |
Why?
|
Child, Preschool | 3 | 2021 | 42577 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5690 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 11920 | 0.040 |
Why?
|
Child | 5 | 2021 | 80668 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 891 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2023 | 1250 | 0.040 |
Why?
|
Missouri | 1 | 2017 | 113 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20144 | 0.040 |
Why?
|
Cladribine | 1 | 2017 | 34 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3792 | 0.040 |
Why?
|
Trichosporon | 1 | 2017 | 9 | 0.040 |
Why?
|
Filgrastim | 1 | 2017 | 132 | 0.040 |
Why?
|
Mitoxantrone | 1 | 2017 | 148 | 0.040 |
Why?
|
Idarubicin | 1 | 2017 | 59 | 0.040 |
Why?
|
Cryptococcus | 1 | 2017 | 28 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2021 | 59550 | 0.030 |
Why?
|
Signal Transduction | 3 | 2017 | 23619 | 0.030 |
Why?
|
Saccharomyces | 1 | 2017 | 62 | 0.030 |
Why?
|
Echinocandins | 1 | 2017 | 57 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2024 | 1802 | 0.030 |
Why?
|
Nuclear Family | 1 | 2018 | 311 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 630 | 0.030 |
Why?
|
Lipopeptides | 1 | 2017 | 73 | 0.030 |
Why?
|
Amphotericin B | 1 | 2017 | 140 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 2021 | 729 | 0.030 |
Why?
|
Cell Degranulation | 1 | 2017 | 276 | 0.030 |
Why?
|
Cryopreservation | 1 | 2021 | 727 | 0.030 |
Why?
|
Living Donors | 1 | 2021 | 647 | 0.030 |
Why?
|
Graft Rejection | 2 | 2021 | 4504 | 0.030 |
Why?
|
Steroids | 1 | 2021 | 936 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2016 | 146 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1852 | 0.030 |
Why?
|
Etoposide | 1 | 2017 | 638 | 0.030 |
Why?
|
Adenine | 1 | 2021 | 993 | 0.030 |
Why?
|
Perforin | 1 | 2015 | 167 | 0.030 |
Why?
|
Drug Evaluation | 1 | 2016 | 642 | 0.030 |
Why?
|
Drug Resistance | 1 | 2021 | 1592 | 0.030 |
Why?
|
Phenotype | 2 | 2024 | 16724 | 0.030 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2021 | 950 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2020 | 834 | 0.030 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2015 | 306 | 0.030 |
Why?
|
Mycoses | 1 | 2017 | 389 | 0.030 |
Why?
|
Granzymes | 1 | 2015 | 278 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2017 | 2012 | 0.030 |
Why?
|
Electroencephalography | 1 | 2009 | 6282 | 0.030 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 220 | 0.030 |
Why?
|
Cell Lineage | 1 | 2022 | 2572 | 0.030 |
Why?
|
Fetal Blood | 1 | 2020 | 1367 | 0.030 |
Why?
|
STAT5 Transcription Factor | 1 | 2014 | 269 | 0.030 |
Why?
|
Integrins | 1 | 2017 | 839 | 0.030 |
Why?
|
Calcineurin | 1 | 2013 | 235 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 1998 | 0.030 |
Why?
|
Neutropenia | 1 | 2017 | 894 | 0.020 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 685 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2021 | 2839 | 0.020 |
Why?
|
Lymphocytes | 1 | 2019 | 2605 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1885 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1756 | 0.020 |
Why?
|
Models, Immunological | 1 | 2013 | 517 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 15657 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2013 | 899 | 0.020 |
Why?
|
Infant | 1 | 2013 | 36461 | 0.020 |
Why?
|
Lentivirus | 1 | 2013 | 518 | 0.020 |
Why?
|
Prospective Studies | 3 | 2021 | 54871 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3944 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2013 | 1525 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3434 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 13036 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4853 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29948 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2015 | 14471 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18330 | 0.020 |
Why?
|
Interleukins | 1 | 2013 | 795 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4443 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8728 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8891 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5923 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4410 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11872 | 0.020 |
Why?
|
Anticoagulants | 1 | 2021 | 4855 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2013 | 2039 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9244 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2014 | 2391 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8540 | 0.020 |
Why?
|
NF-kappa B | 1 | 2013 | 2493 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6779 | 0.020 |
Why?
|
RNA Interference | 1 | 2013 | 2827 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2017 | 3408 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4142 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2013 | 2881 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2013 | 3401 | 0.010 |
Why?
|
United States | 2 | 2021 | 72951 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36567 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8735 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15908 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13640 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 24295 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22352 | 0.010 |
Why?
|